Assuming an average change in eGFR of @ @ ( SD ) mL/min/@ @ m ( @ ) per year in untreated patients , @ patients are needed in each group to detect a @ % reduction in the rate of kidney function loss between treatment groups with @ % power , @-sided = @ , and @ % protocol violators and/or dropouts .